Publications by authors named "A Dovio"

Intense physical exercise activates the hypothalamic-pituitary-adrenocortical axis but little is known about changes in glucocorticoid sensitivity at the target cell level. No data are available on the acute effects of exercise on 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 activity, which generates biologically active cortisol from inactive cortisone and is expressed also in skeletal muscle. Fifteen healthy, trained males (age mean +/- SE 28 +/- 1) were assessed on three non-consecutive days: at rest, during an endurance and strength sessions.

View Article and Find Full Text PDF

Glucocorticoids (GCs) are widely used for the treatment of hormone refractory prostate cancer. However, few data are available on the expression and regulation of glucocorticoid and mineralocorticoid receptors (GR and MR) and 11beta-hydroxysteroid dehydrogenase (11beta-HSD) 1 and -2 activities in prostate cancer cells. Here we show that GR is expressed in both the androgen-independent PC-3 cell line and, at very low levels, in the androgen-dependent LNCaP cells, and MR is expressed in both cell lines.

View Article and Find Full Text PDF

In recent years, increased awareness and availability of proper diagnostic tools have made subclinical endocrine disease an emerging issue. The clinical impact of subtle alterations of hormonal secretion and/or action depends on the sensitivity of target cells, which shows wide interindividual variability, and within the same individual, varies among tissues and changes in particular microenvironments, e.g.

View Article and Find Full Text PDF

Objective: .Microvascular damage is an early pathogenetic event in systemic sclerosis (SSc). The receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin (OPG) system is involved in vascular biology.

View Article and Find Full Text PDF
Article Synopsis
  • The circadian rhythm of bone turnover in breast cancer patients suggests that bisphosphonates like zoledronic acid may be more effective if given at night.
  • A study with 44 breast cancer patients examined the effects of administering zoledronic acid either in the morning or at night, measuring various bone turnover markers over time.
  • Results showed similar decreases in key markers of bone turnover regardless of administration time, but nocturnal administration led to higher urinary levels of the drug and a smaller increase in serum parathyroid hormone levels.
View Article and Find Full Text PDF